MindWalk Holdings (HYFT) Amortization (2020 - 2026)
MindWalk Holdings (HYFT) reported Amortization of $13.6 million for Q1 2026, up 850.43% year-over-year from $1.4 million in Q1 2025, and down 13.48% quarter-over-quarter from $15.7 million in Q4 2025.
MindWalk Holdings (HYFT) Amortization (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Amortization data on file, last reported at $13.6 million in Q1 2026.
- Amortization for Q1 2026 came in at $13.6 million, up 850.43% year-over-year; the trailing twelve-month figure through Jan 2026 was $13.6 million (down 4.94% YoY), and the FY2025 annual result was $17.0 million, down 44.15% from the prior year.
- Amortization retreated to $13.6 million in Q1 2026 per HYFT's latest filing, from $15.7 million in the prior quarter.
- Over five years, Amortization peaked at $46.5 million in Q4 2022 and troughed at $1.4 million in Q1 2025.
- A 5-year average of $13.0 million and a median of $5.5 million in 2023 frame the typical range for Amortization.
- The sharpest annual moves came in 2022 and 2024: Amortization surged 2791.63% in 2022, then tumbled 96.14% in 2024.
- A 5-year view of Amortization shows it stood at $46.5 million in 2022, then retreated by 17.45% to $38.4 million in 2023, then plunged by 96.14% to $1.5 million in 2024, then soared by 957.28% to $15.7 million in 2025, then slipped by 13.48% to $13.6 million in 2026.
- Business Quant data shows HYFT's Amortization at $13.6 million in Q1 2026, $15.7 million in Q4 2025, and $3.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -13.75 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 13.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 13.56 Mn |
| Jan 31, 2026 | 13.56 Mn |
| Oct 31, 2025 | 15.67 Mn |
| Oct 31, 2025 | 15.67 Mn |
| Jul 31, 2025 | 3.66 Mn |
| Jul 31, 2025 | 3.66 Mn |
| Apr 30, 2025 | 11.08 Mn |
| Apr 30, 2025 | 11.08 Mn |
| Jan 31, 2025 | 1.43 Mn |
| Jan 31, 2025 | 1.43 Mn |
| Oct 31, 2024 | 1.48 Mn |
| Oct 31, 2024 | 1.48 Mn |
| Jul 31, 2024 | 23.99 Mn |
| Jul 31, 2024 | 23.99 Mn |
| Apr 30, 2024 | 9.86 Mn |
| Apr 30, 2024 | 9.86 Mn |
| Jan 31, 2024 | 1.50 Mn |
| Jan 31, 2024 | 1.50 Mn |
| Oct 31, 2023 | 38.37 Mn |
| Oct 31, 2023 | 38.37 Mn |